Prospective multicenter study finds 46.4% eight-week hemoglobin response to Zaizao Shengxue capsule
A prospective multicenter observational study found that 46.4% of 440 analyzed patients responded to eight weeks of Zaizao Shengxue capsule, ...
A prospective multicenter observational study found that 46.4% of 440 analyzed patients responded to eight weeks of Zaizao Shengxue capsule, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine